MO4 TRANSFERABILITY OF MODEL-BASED ECONOMIC EVALUATIONS- THE CASE OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS
Abstract
Authors
MA Joore V Tjan Heijnen JL Severens A Novk U Oron M Pompen BA Essers